The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,994,176 in first-year total cost, median $999,919.
Most frequent study sections
- Special Emphasis Panel[ZCA1 TCRB-9 (J3)]7
Most frequent institutions
- ALTOR BIOSCIENCE. LLC1
- CHRONO THERAPEUTICS, INC.1
- EUTROPICS PHARMACEUTICALS, INC.1
- FIBRALIGN CORPORATION1
- NUVOX PHARMA, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Programmable Individualized NRT Merged With Digital Behavioral Support2R44CA171786-04 | LEVY, ALAN JOEL | CHRONO THERAPEUTICS, INC., CA | $1,000,000 | ZCA1 |
| 2017 | DEVELOPMENT OF A WNT PATHWAY INHIBITOR FOR METASTATIC COLORECTAL CANCER2R44CA144177-04A1 | ORTON, DARREN | STEMSYNERGY THERAPEUTICS, INC., FL | $1,000,000 | ZCA1 |
| 2017 | Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation of Glioblastoma2R44CA144817-03 | STEA, BALDASSARREUNGER, EVAN CHARLES | NUVOX PHARMA, LLC, AZ | $1,000,000 | ZCA1 |
| 2017 | Novel IL-15 Superagonist Therapy for Bladder Cancer2R44CA156740-04 | RHODE, PETER R | ALTOR BIOSCIENCE. LLC, FL | $999,919 | ZCA1 |
| 2017 | Commercializing Praedicare Dx TM platform for guiding cancer treatments2R44CA203610-02A1 | CARDONE, MICHAEL H | EUTROPICS PHARMACEUTICALS, INC., MA | $998,807 | ZCA1 |
| 2017 | Prospective evaluation of a surgical solution for breast cancer-associated lymphedema2R44CA203608-02A1 | PAUKSHTO, MICHAEL VITOLDOVICHROCKSON, STANLEY G | FIBRALIGN CORPORATION, CA | $997,783 | ZCA1 |
| 2017 | A Novel PET Probe for Use in Cancer Diagnostics2R44CA216539-02 | MOORE, MELISSA | SOFIE BIOSCIENCES, INC., CA | $997,667 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.